Ofev 100 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,954
Award facts
- Contract value 100% obligated
- $18,953.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,953.52 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 14, 2026, for the supply of Ofev 100 mg capsules (60-count units), with an ultimate completion date of February 5, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Ofev (nintedanib) is a specialty pharmaceutical used primarily for treating idiopathic pulmonary fibrosis and other progressive fibrosing interstitial lung diseases. The delivery order represents a routine task order under the established pharmaceutical prime vendor relationship between DLA and Amerisourcebergen, reflecting the company's critical role in supporting the Defense Health Agency and broader military healthcare systems with essential prescription medications across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCZ7B?
SPE2DR26FCZ7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ7B worth?
The government has obligated $18,954 on SPE2DR26FCZ7B.
Is contract SPE2DR26FCZ7B an order under another contract?
Yes. SPE2DR26FCZ7B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ7B competed?
The extent of competition for SPE2DR26FCZ7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award